All News and Events

25 March 2026

Event jointly organized by: AVE and St Vincent's Institute of Medical Research

21 May 2025

Event jointly organized by : Institute for Bioengineering of Catalunya (IBEC) and Centre for Genomic Regulation (CRG)

22 May 2024

Our 7th Annual Mutational Scanning Symposium will be held at the Broad Institute in Cambridge Massachusetts May 22-24th, 2024

9 June 2025

BBI’s Shawn Fayer and Noelia Ferruz Capapey, a Group Leader at the Centre for Genomic Regulation in Barcelona, reflect on the 8th annual Mutational Scanning Symposium.

30 May 2025

Field of VEPs has grown rapidly, without clear standards

30 April 2025

Researchers from the Institute of Genetics and Cancer have been working with the Atlas of Variant Effects Alliance to provide practical guidelines for releasing new computational tools known as variant effect predictors (VEPs).

30 June 2025

Who do you ask if you have a question about a gene? In this episode, we dive into the teams and scientists that are building an encyclopedia of knowledge about your genes.

Transcript and show notes can be found here.

23 March 2025

We can predict the weather, but can we predict genetic diseases from your genome?

In this episode we explain the challenges and the promises of variant effect predictors (VEPs)

with experts Dr Debbie Marks and Dr Joe Marsh

8 November 2024

In this bonus episode, we interview scientists at the 7th Annual Mutational Scanning Symposium which took place May 22-24, 2024 at the Broad Institute. Here we chat about the future of this field, funny lab experiences, and how people got interested in variant interpretation. (We want to thank Dr. Buchser, Dr. Cagiada, Dr. Deyell, Dr. Kinney, Mr. Smith, and everybody else at MSS2024 for their participation.)

2 September 2025

Jonuelle (Jon) Acosta is a postdoctoral fellow at MIT co-mentored by Francisco Sánchez-Rivera and Michael Hemann. He completed his PhD at the University of Pennsylvania in David Feldser's laboratory, where he utilized tractable mouse models of cancer to model the impact of p53 restorative therapies in small cell carcinoma.  As an F31 predoctoral fellow,  he identified novel context-dependent mechanisms of p53-mediated tumor suppression that may be utilized to develop novel strategies to treat this aggressive cancer subtype, and others. During...morehis postdoctoral work, he is integrating next-generation genome editing technology with complex ex vivo and in vivo platforms to understand how cellular context influences genetic interactions, and its impact on cancer progression and evolution.

2 September 2025

Christina is a doctoral clinical fellow in the Genome Function Lab at the Francis Crick Institute, where she develops prime editing-based high-throughput methods to investigate the functional impact of genetic variants, with a focus on non-coding regions. She previously earned her medical degree from the University of Göttingen and conducted research at Rockefeller University on genetic drivers of cancer metastasis. She will co-present a recently established prime editing variant screening platform in haploid human cells alongside Michael Herger.

2 September 2025

Michael Herger is a biologist with a special interest in interrogating the function, interactions, and mechanisms of epigenetic factors using scalable functional genomics tools. Currently, he is a postdoctoral fellow in Greg Findlay’s Lab at the Francis Crick Institute (London, UK) and previously earned his PhD at the University of Cambridge, focusing on directed evolution of CRISPR/Cas reagents. He will be co-presenting recent work on pooled prime editing screens in human haploid cells together with Christina Kajba.